Entelexo Biotherapeutics
New accelerator entry · 2021-03-05 · the record
In their words
Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.
What the record says
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Entelexo Biotherapeutics
- Source Check — verify what Entelexo Biotherapeutics states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Entelexo Biotherapeutics for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Entelexo BiotherapeuticsYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Entelexo Biotherapeutics: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.
